Antifungal prophylaxis with micafungin in patients treated for childhood cancer

Pediatric Blood and Cancer

Volumn 53, Issue 4, 2009, Pages 605-609

  Kusuki, Shigenori ^a   Hashii, Yoshiko ^a   Yoshida, Hisao ^a   Takizawa, Sachiko ^a   Sato, Emiko ^a   Tokimasa, Sadao ^a   Ohta, Hideaki ^a   Ozono, Keiichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anitifungal prophylaxis; Chemotherapy; Children; Hematopoietic stem cell transplantation; Micafungin

Indexed keywords

ANTINEOPLASTIC AGENT; MICAFUNGIN; ANTIFUNGAL AGENT; BETA GLUCAN; ECHINOCANDIN; LIPOPEPTIDE;

ACUTE LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANDIDA PARAPSILOSIS; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MULTIPLE CYCLE TREATMENT; MYCOSIS; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SOLID TUMOR; TREATMENT OUTCOME; BLOOD; INFANT; NEOPLASM;

ADOLESCENT; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; BETA-GLUCANS; CHILD; CHILD, PRESCHOOL; ECHINOCANDINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LIPOPEPTIDES; MYCOSES; NEOPLASMS; NEUTROPENIA; RETROSPECTIVE STUDIES;

EID: 69849086871     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22140     Document Type: Article

References (31)

1. Cap J, Mojzesova A, Kayserova E, et al. Fluconazole in children: First experience with prophylaxis in chemotherapy-induced neutropenia in pediatric patients with cancer. Chemotherapy 1993;39:438-442. (Pubitemid 23283672)
2. Wingard JR. Antifungal chemoprophylaxis after blood and marrow transplantation. Clin Infect Dis 2002;34:1386-1390. (Pubitemid 34507949)
3. Hachem R, Hanna H, Kontoyiannis D, et al. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008;112:2493-2499.
4. Denning DW. Echinocandin antifungal drugs. Lancet 2003;362:1142-1151.
5. Joseph JM, Jain R, Danziger LH. Micafungin: A new echinocandin antifungal. Pharmacotherapy 2007;27:53-67.
6. van Burik JA, Ratanatharathorn V, Stepan DE, et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004;39:1407-1416. (Pubitemid 39518200)
7. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-1821.
8. Senn L, Robinson JO, Schmidt S, et al. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008;46:878-885.
9. Slavin MA, Szer J, Grigg AP, et al. Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections. Intern Med J 2004;34:192-200. (Pubitemid 38651040)
10. Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study. Clin Infect Dis 2005;41:1242-1250. (Pubitemid 41534660)
11. Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis 2006;43:25-31. (Pubitemid 43939072)
12. Yanada M, Kiyoi H, Murata M, et al. Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropenia. Intern Med (Tokyo, Japan) 2006;45:259-264.
13. Kuse ER, Chetchotisakd P, da Cunha CA, et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: A phase III randomised double-blind trial. Lancet 2007;369:1519-1527. (Pubitemid 46670281)
14. Hashino S, Morita L, Takahata M, et al. Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation. Int J Hematol 2008;87:91-97.
15. Kaya Z, Gursel T, Kocak U, et al. Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis. Pediatr Blood Cancer 2009;52:470-475.
16. Grigull L, Kuehlke O, Beilken A, et al. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: A pilot study for evaluation of safety and efficacy. Pediatr Transplant 2007;11:261-266. (Pubitemid 46570141)
17. Pfaller MA, Boyken L, Hollis RJ, et al. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance. J Clin Microbiol 2008;46:150-156.
18. F Ikeda, T Saika, Y Sato, et al. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan. Med Mycol 2009;47:145-148.
19. Matsue K, Uryu H, Koseki M, et al. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 2006;42:753-757. (Pubitemid 43363927)
20. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002;20:1898-1906. (Pubitemid 34273282)
21. Penack O, Rempf P, Graf B, et al. Aspergillus galactomannan testing in patients with long-term neutropenia: Implications for clinical management. Ann Oncol 2008;19:984-989. (Pubitemid 351627318)
22. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004;39:199-205. (Pubitemid 38971490)
23. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005;41:654-659. (Pubitemid 41170353)
24. Obayashi T, Negishi K, Suzuki T, et al. Reappraisal of the serum (1→3)-beta-D-glucan assay for the diagnosis of invasive fungal infections - a study based on autopsy cases from 6 years. Clin Infect Dis 2008;46:1864-1870.
25. Toubai T, Tanaka J, Ota S, et al. Efficacy and safety of micafungin in febrile neutropenic patients treated for hematological malignancies. Intern Med (Tokyo, Japan) 2007;46:3-9. (Pubitemid 46062246)
26. Seibel NL, Schwartz C, Arrieta A, et al. Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother 2005;49:3317-3324. (Pubitemid 41060577)
27. Roman E, Osunkwo I, Militano O, et al. Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation. Pediatr Blood Cancer 2008;50:325-330.
28. Bermudez M, Fuster JL, Llinares E, et al. Itraconazole-related increased vincristine neurotoxicity: Case report and review of literature. J Pediatr Hematol Oncol 2005;27:389-392. (Pubitemid 41077029)
29. Graybill JR, Bocanegra R, Gonzalez GM, et al. Combination antifungal therapy of murine aspergillosis: Liposomal amphotericin B and micafungin. J Antimicrob Chemother 2003;52:656-662. (Pubitemid 37258428)
30. Luque JC, Clemons KV, Stevens DA. Efficacy of micafungin alone or in combination against systemic murine aspergillosis. Antimicrob Agents Chemother 2003;47:1452-1455. (Pubitemid 36368619)
31. Olson JA, Adler-Moore JP, Smith PJ, et al. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Antimicrob Agents Chemother 2005;49:4895-4902.